Zobrazeno 1 - 10
of 210
pro vyhledávání: '"Byung Ho Choe"'
Autor:
Yoo Min Lee, Eun Sil Kim, Sujin Choi, Hyo-Jeong Jang, Yu Bin Kim, So Yoon Choi, Byung-Ho Choe, Ben Kang
Publikováno v:
Gut and Liver, Vol 18, Iss 3, Pp 498-508 (2024)
Background/Aims: The recent update on Selecting Therapeutic Targets in Inflammatory Bowel Disease initiative has added a decrease in fecal calprotectin (FC) to an acceptable range as an intermediate target for Crohn’s disease (CD). We aimed to inve
Externí odkaz:
https://doaj.org/article/12143e74ece14a1db960090bd503042d
Autor:
So Yoon Choi, Sujin Choi, Byung-Ho Choe, Jae Hong Park, Kwang-Hae Choi, Hae Jeong Lee, Ji Sook Park, Ji-Hyun Seo, Jae Young Kim, Hyo-Jeong Jang, Suk Jin Hong, Eun Young Kim, Yeoun Joo Lee, Ben Kang
Publikováno v:
Gut and Liver, Vol 18, Iss 1, Pp 106-115 (2024)
Background/Aims: The recent update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease initiative has added normal growth in children as an intermediate target in Crohn’s disease and ulcerative colitis. We aimed to investigate factor
Externí odkaz:
https://doaj.org/article/94977da0d75c405eaa553425dccbb00f
Autor:
Eun Sil Kim, Sujin Choi, Byung-Ho Choe, Sowon Park, Yeoun Joo Lee, Sang Jun Sohn, Soon Chul Kim, Ki Soo Kang, Kunsong Lee, Jung Ok Shim, Yu Bin Kim, Suk Jin Hong, Yoo Min Lee, Hyun Jin Kim, So Yoon Choi, Ju Young Kim, Yoon Lee, Ji-Sook Park, Jae Young Kim, Dae Yong Yi, Ji Hyuk Lee, Kwang-Hae Choi, Hyo-Jeong Jang, In Sook Jeong, Ben Kang
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Background and aimsFavourable clinical data were published on the efficacy of CT-P13, the first biosimilar of infliximab (IFX), in pediatric inflammatory bowel disease (IBD); however, few studies have compared the effect on endoscopic healing (EH) an
Externí odkaz:
https://doaj.org/article/f0ec83062855423d947396290d1f5ac3
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
Background and aimBowel preparation for pediatric colonoscopy presents several challenges. However, no bowel preparation regimen is universally preferred for children. We aimed to investigate the efficacy and safety of oral sulfate tablet (OST) in pe
Externí odkaz:
https://doaj.org/article/317cde6f0c7b4171a14a51f892ab1f38
Autor:
Ju Young Kim, Yu Bin Kim, Sujin Choi, Yoo Min Lee, Hyun Jin Kim, Soon Chul Kim, Hyo-Jeong Jang, So Yoon Choi, Dae Yong Yi, Yoon Lee, You Jin Choi, Yunkoo Kang, Kyung Jae Lee, Suk Jin Hong, Jun Hyun Hwang, Sanggyu Kwak, Byung-Ho Choe, Ben Kang
Publikováno v:
Gut and Liver, Vol 17, Iss 3, Pp 441-448 (2023)
Background/Aims: A full colonoscopy is currently required in children and adolescents with colorectal polyps, because of their potential of neoplastic transformation and complications such as intussusception. We aimed to analyze the associations of p
Externí odkaz:
https://doaj.org/article/ab7b149a469c4cffb88f9ef1b1d9a189
Autor:
Sowon Park, Ben Kang, Seung Kim, Sujin Choi, Hyo Rim Suh, Eun Sil Kim, Ji Hyung Park, Mi Jin Kim, Yon Ho Choe, Yeoun Joo Lee, Jae Hong Park, Eell Ryoo, Hong Koh, Byung-Ho Choe
Publikováno v:
Gut and Liver, Vol 16, Iss 6, Pp 921-929 (2022)
Background/Aims: We aimed to compare the differences in pediatric Crohn’s disease (CD) and ulcerative colitis (UC) at diagnosis in Korea. Methods: This was a multicenter, registry-based, inception cohort study conducted at five centers in Korea bet
Externí odkaz:
https://doaj.org/article/2eb05daafe80493bb83c359719d18f82
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionIt is well known that infliximab (IFX) trough levels (TLs) are associated with endoscopic healing (EH) in Crohn’s disease (CD). We investigated whether IFX TLs are associated with transmural healing (TH) in pediatric patients with CD fo
Externí odkaz:
https://doaj.org/article/651a676623bc4a8a806ed228d1c6a8b2
Autor:
Yoo Min Lee, Sujin Choi, Byung-Ho Choe, Hyo-Jeong Jang, Seung Kim, Hong Koh, Eun Sil Kim, Mi Jin Kim, Yon Ho Choe, Ben Kang
Publikováno v:
Gut and Liver, Vol 16, Iss 1, Pp 62-70 (2022)
Background/Aims: Although mucosal healing (MH) is acknowledged as the treatment target in the treat-to-target era, there are limitations on repeated endoscopic examinations, especially in pediatric patients. We aimed to investigate whether fecal calp
Externí odkaz:
https://doaj.org/article/5a3c3dad66d943d0840b41ae8cdff5f4
Publikováno v:
Gut and Liver, Vol 15, Iss 4, Pp 588-598 (2021)
Background/Aims: Anti-drug antibodies (ADAs) can develop during treatment with anti-tumor necrosis factor (TNF) agents. We aimed to investigate the factors associated with immunogenicity of anti-TNF agents in pediatric patients with inflammatory bowe
Externí odkaz:
https://doaj.org/article/7042abe0c262464ea3dd5da35e9ea87a
Publikováno v:
Yeungnam University Journal of Medicine, Vol 38, Iss 3, Pp 251-257 (2021)
Vedolizumab (VDZ) has been approved for the treatment of inflammatory bowel diseases (IBDs) in patients aged ≥18 years. We report a case of a pediatric patient with Crohn disease (CD) who was successfully treated with VDZ. A 16-year-old female deve
Externí odkaz:
https://doaj.org/article/3899b60093ae44b8bbb647061c1cdc54